SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
229 hedge funds and large institutions have $640M invested in Sorrento Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
229
Holders Change
+11
Holders Change %
+5.05%
% of All Funds
4.03%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
44
Increased
71
Reduced
67
Closed
31
Calls
$75.7M
Puts
$39.3M
Net Calls
+$36.5M
Net Calls Change
-$5.93M
Top Buyers
| 1 |
BlackRock
New York
|
+$14.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$8.81M |
| 4 |
JPMorgan Chase & Co
New York
|
+$8.12M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.31M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$23.9M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$14.5M |
| 3 |
Goldman Sachs
New York
|
-$10.4M |
| 4 |
Morgan Stanley
New York
|
-$9.45M |
| 5 |
Jane Street
New York
|
-$7.23M |
